First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction.

Pi-Cardia today announced the first commercial procedures with its ShortCut leaflet modification device for enabling heart ...

Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treating heart valves, announced today the first commercial procedures with ShortCuttm - the world's first ...

First dedicated leaflet modification solution to enable TAVR in patients at risk of coronary obstruction Pi-Cardia Inc., a global leader in the development of leaflet modification solutions for treati ...

Sue Dumbauld's job was straining her heart. After losing weight, improving her cholesterol, she was in great shape for ...

system demonstrates favourable clinical outcomes and valve performance at 30 days in patients with severe bicuspid aortic valve (BAV) stenosis. Severe BAV stenosis presents a unique challenge for TAVI ...

Valve‐in‐valve transcatheter aortic valve replacement (TAVR ... Conversely, the younger group had a higher body mass index and a more frequent occurrence of bicuspid aortic valves.

Based on the results from the MATTERHORN (A Multicenter, Randomized, Controlled Study to Assess Mitral Valve Reconstruction for Advanced Insufficiency of Functional or Ischemic Origin), transcatheter ...

However, there are key differences in the studies that make a 1:1 comparison difficult. For one, the patients in the RESHAPE-HF2 trial had less severe mitral valve regurgitation than did those in the ...

2 Centre National de Référence pour le syndrome de Marfan et apparentés, Hôpital Bichat, AP-HP, Paris, France Background Bicuspid aortic valve (BAV) is related to aortic dilatation, but patterns/rates ...

Become familiar with the different echocardiographic methods used for heart valve evaluation. Know the strength and limitations of echocardiography for evaluation of valve disease. Patients with ...